Literature DB >> 8198395

Molecular genetics of human thyroid neoplasms.

J A Fagin1.   

Abstract

Cancers are thought to develop as a result of sequential mutations of genes important in the control of cellular growth. Recently investigators identified a number of genetic defects that affect oncogenes and tumor-suppressor genes and that provide insight into the biology of benign and malignant thyroid neoplasms. Future implications for thyroid tumor diagnosis and prognosis are considered in this chapter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198395     DOI: 10.1146/annurev.med.45.1.45

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  9 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Distinguishing molecular markers in thyroid tumors: a tribute to Dr. Orlo Clark.

Authors:  Martha A Zeiger
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

3.  Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.

Authors:  Matthew A Nehs; Sushruta Nagarkatti; Carmelo Nucera; Richard A Hodin; Sareh Parangi
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

4.  Recurrent thyroid cancer with changing histologic features.

Authors:  S Michelle Shiller; Kartik Konduri; Leeanne K Harshman; Brian J Welch; John C O'Brien
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-07

5.  From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.

Authors:  X Chen; J A Knauf; R Gonsky; M Wang; E H Lai; S Chissoe; J A Fagin; J R Korenberg
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

6.  A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.

Authors:  Colin J Mooney; Govardhanan Nagaiah; Pingfu Fu; Jay K Wasman; Matthew M Cooney; Panos S Savvides; Joseph A Bokar; Afshin Dowlati; Ding Wang; Sanjiv S Agarwala; Susan M Flick; Paul H Hartman; Jose D Ortiz; Pierre N Lavertu; Scot C Remick
Journal:  Thyroid       Date:  2009-03       Impact factor: 6.568

7.  Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.

Authors:  Panayiotis Savvides; Govardhanan Nagaiah; Pierre Lavertu; Pingfu Fu; John J Wright; Robert Chapman; Jay Wasman; Afshin Dowlati; Scot C Remick
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

8.  A rare association of extragonadal seminoma with synchronous papillary carcinoma of the thyroid.

Authors:  Craig Barrington; Gianfilippo Bertelli; Rhodri Evans
Journal:  BMJ Case Rep       Date:  2014-03-13

Review 9.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.